HEALTHJun 23 · 14:22 UTCSTAT NEWSJohn Wilkerson

STAT+: Exclusive: Mystery man gets experimental GLP-1

A man was granted compassionate-use access to an experimental GLP-1 drug developed by Eli Lilly. The exclusive report details the sole individual given special access to the obesity treatment, as covered in STAT's health policy newsletter.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Lizzy LawrencepersonEli LillyorganizationGLP-1topiccompassionate usetopicSTATorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 23 · 08:30 UTC
STAT+: Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
HEALTHJun 23 · 13:06 UTC
STAT+: Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program
HEALTHMay 16 · 12:41 UTC
First human GLP-1 gene therapy trial gets green light
HEALTHJun 8 · 10:00 UTC
How an experimental weight-loss drug is being openly promoted by physicians
HEALTHMay 30 · 13:25 UTC
STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug
HEALTHJun 9 · 00:54 UTC
Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA